May 14, 2024 6:00 am EDT Codexis Presents Groundbreaking Enzymatic Synthesis Data at TIDES USA Annual Meeting Read More
Feb 28, 2024 4:05 pm EST Codexis Reports Fourth Quarter and Fiscal Year 2023 Financial Results Read More
Feb 26, 2024 4:05 pm EST Codexis Enters Exclusive Licensing Agreement for Newly Engineered Double-Stranded DNA Ligase with Roche Read More
Feb 26, 2024 8:05 am EST Codexis to Participate in TD Cowen 44th Annual Health Care Conference Read More
Feb 20, 2024 8:05 am EST Codexis Announces Appointment of Masad Damha, PhD, and Jim Lalonde, PhD, to Strategic Advisory Board Read More